MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Phase 1 MAD Data for DA-1726 On April 15, 2025, MetaVia Inc. (NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

That was music to the ears of investors in Novo Nordisk, which makes diabetes and obesity treatments Ozempic and Wegovy; and in Eli Lilly, which makes Mounjaro and Zepbound diabetes and obesity drugs.

Former speed skater Sarah Lindsay, 44, believes injections like Ozempic and Mounjaro are causing users to be malnourished and ...

He also expects Lilly to have an early entry advantage over Novo's Wegovy, which has the same active ingredient as its diabetes medicine Ozempic that is often used off-label for weight loss.

Real-time index price for TSX Oil and Gas EW Index (TXOE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

NORTH CAROLINA (WTVD) -- A warning to consumers about fake Ozempic (semaglutide). The FDA issued this alert saying counterfeits have been found in the US drug supply chain. The FDA and the ...

Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in diet-induced obesity modelNew in vitro data demonstrates ...

In 2024, roughly 5 per cent of Britons had used an injectable glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications known under brand names such as Wegovy, Ozempic and ... 1 drugs ...

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...